Rational Tuning of CAR Tonic Signaling Yields Superior T-Cell Therapy for Cancer
preprint
OA: closed
Abstract
SUMMARY Chimeric antigen receptors (CARs) are modular proteins capable of redirecting immune cells toward a wide variety of disease-associated antigens. Here, we explore the effects of CAR protein sequence and structure on CAR-T cell function. Based on the empirical observation that CD20 CARs with similar sequences exhibit divergent tonic-signaling and anti-tumor activities, we devised engineering strategies that aimed to improve CAR-T cell function by tuning the intensity of tonic signaling. We found that CARs designed to exhibit low but non-zero levels of tonic signaling show robust effector function upon antigen stimulation while avoiding premature functional exhaustion by CAR-T cells. Through alterations of the CAR’s ligand-binding domain and overall protein conformation, we generated CD20 CAR variants that outperform the CD19 CAR in mouse models of human lymphoma. We further demonstrate that rational modification of protein confirmation can be generalized to improve GD2 CAR-T cell efficacy against neuroblastoma. These findings point to tonic signaling and basal T-cell activation as informative parameters to guide the rational design of next-generation CARs for cancer therapy.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (61)
- doi:10.1038/nri.2017.99 via crossref
- doi:10.1038/nprot.2008.107 via crossref
- doi:10.1182/blood-2012-03-416867 via crossref
- doi:10.1038/nmeth.2688 via crossref
- doi:10.1016/j.cell.2013.05.016 via crossref
- doi:10.1016/j.cell.2015.08.016 via crossref
- doi:10.1016/j.molmed.2017.03.002 via crossref
- doi:10.1038/nchembio.2565 via crossref
- doi:10.1016/0022-2836(87)90412-8 via crossref
- doi:10.1038/342877a0 via crossref
- doi:10.1002/0471250953.bi1411s37 via crossref
- doi:10.1073/pnas.081069198 via crossref
- doi:10.1038/nmeth.4396 via crossref
- doi:10.1038/srep24129 via crossref
- doi:10.1158/1078-0432.ccr-18-2559 via crossref
- doi:10.1182/blood-2006-07-035972 via crossref
- doi:10.1158/2326-6066.cir-14-0186 via crossref
- doi:10.1016/j.celrep.2017.09.015 via crossref
- doi:10.1016/j.tmrv.2019.01.005 via crossref
- doi:10.1016/j.ceb.2011.05.003 via crossref
- doi:10.1016/j.ccell.2020.07.005 via crossref
- doi:10.1158/1078-0432.ccr-13-0330 via crossref
- doi:10.1158/2326-6066.cir-14-0127 via crossref
- doi:10.1053/bbmt.1998.v4.pm9763110 via crossref
- doi:10.1111/j.1749-6632.1971.tb13550.x via crossref
- doi:10.1016/j.cmet.2017.06.016 via crossref
- doi:10.1073/pnas.0503726102 via crossref
- doi:10.4161/mabs.24108 via crossref
- doi:10.1016/j.tibs.2015.12.001 via crossref
- doi:10.1002/bit.21961 via crossref
- doi:10.1158/0008-5472.can-15-0159 via crossref
- doi:10.1038/nm.3838 via crossref
- doi:10.1016/j.cmet.2014.05.004 via crossref
- doi:10.1038/s41591-019-0564-6 via crossref
- doi:10.1158/2159-8290.cd-19-0945 via crossref
- doi:10.1006/jmbi.1996.0617 via crossref
- doi:10.1182/blood-2009-06-225979 via crossref
- doi:10.1182/blood-2010-09-305847 via crossref
- doi:10.1006/jmbi.2000.4042 via crossref
- doi:10.1038/s41589-019-0364-9 via crossref
- doi:10.1182/blood-2004-06-2482 via crossref
- doi:10.1182/blood.v83.2.435.435 via crossref
- doi:10.1158/2326-6066.cir-15-0276 via crossref
- doi:10.1038/s41589-018-0046-z via crossref
- doi:10.1186/s12864-015-2012-4 via crossref
- doi:10.1016/j.it.2015.06.004 via crossref
- doi:10.1016/j.jmb.2016.08.019 via crossref
- doi:10.1091/mbc.e16-08-0586 via crossref
- doi:10.4049/jimmunol.177.1.362 via crossref
- doi:10.1182/blood-2011-10-387969 via crossref
- doi:10.1111/j.1349-7006.2009.01392.x via crossref
- doi:10.4049/jimmunol.1402346 via crossref
- doi:10.1080/2162402x.2016.1253656 via crossref
- doi:10.1158/2326-6066.cir-19-0908 via crossref
- doi:10.1038/s41591-019-0596-y via crossref
- doi:10.1073/pnas.242600099 via crossref
- doi:10.1158/2326-6066.cir-15-0231 via crossref
- doi:10.1038/s41467-020-16160-5 via crossref
- doi:10.1158/1078-0432.ccr-17-0855 via crossref
- doi:10.1038/sigtrans.2016.2 via crossref
- doi:10.1016/j.ccell.2015.09.004 via crossref
Source provenance
- crossref
- last seen: 2026-06-26T06:32:45.412193+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-19T06:49:21.617583+00:00